| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ati-502 | janus kinase 1 | NA | Successful target | TTD | Dermatitis Atopic[MeSHID:D003876] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Eczema[MeSHID:D004485] Vitiligo[MeSHID:D014820] |
NA | phase 2 | unknown |
| ati-502 | janus kinase 1 | NA | Successful target | TTD | Dermatitis Atopic[MeSHID:D003876] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Alopecia[MeSHID:D000505] Eczema[MeSHID:D004485] |
NA | phase 2 | unknown |
| ati-502 | janus kinase 3 | NA | Successful target | TTD | Dermatitis Atopic[MeSHID:D003876] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Alopecia[MeSHID:D000505] Eczema[MeSHID:D004485] |
NA | phase 2 | unknown |
| ati-502 | janus kinase 3 | NA | Successful target | TTD | Dermatitis Atopic[MeSHID:D003876] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Eczema[MeSHID:D004485] Vitiligo[MeSHID:D014820] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||